131I-Epidepride

碘[131I]依匹必利

Report date: 2025/11/24 17:58:18

NME

Base Information

Drug Name131I-Epidepride

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 131I +[4]

Mechanisms of ActionDopamine D2 receptor agonists

TargetsDopamine D2 receptor

Therapy Area/IndicationsContrast agents

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (IND)

Highest Status in ChinaPending

Originator CompaniesJiangsu Institute Of Nuclear Medicine

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A

Inactive CompaniesJiangsu Institute Of Nuclear Medicine

Active IndicationsN/A

Inactive IndicationsContrast agents

Other Information

ATC CodeN/A